OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of gemigliptin, a dipeptidyl peptidase‐4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24‐week, multicentre, randomized, double‐blind, placebo‐controlled study (TROICA study)
Chang Ho Ahn, Kyung Ah Han, Jae Myung Yu, et al.
Diabetes Obesity and Metabolism (2016) Vol. 19, Iss. 5, pp. 635-643
Closed Access | Times Cited: 15
Chang Ho Ahn, Kyung Ah Han, Jae Myung Yu, et al.
Diabetes Obesity and Metabolism (2016) Vol. 19, Iss. 5, pp. 635-643
Closed Access | Times Cited: 15
Showing 15 citing articles:
Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
Deep Dutta, Anshita Agarwal, Indira Maisnam, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 2, pp. 374-387
Open Access | Times Cited: 38
Deep Dutta, Anshita Agarwal, Indira Maisnam, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 2, pp. 374-387
Open Access | Times Cited: 38
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
Min Kyong Moon, Kyu Yeon Hur, Seung‐Hyun Ko, et al.
Diabetes & Metabolism Journal (2017) Vol. 41, Iss. 5, pp. 357-357
Open Access | Times Cited: 40
Min Kyong Moon, Kyu Yeon Hur, Seung‐Hyun Ko, et al.
Diabetes & Metabolism Journal (2017) Vol. 41, Iss. 5, pp. 357-357
Open Access | Times Cited: 40
Efficacy and safety of aromatase inhibitors in the management of idiopathic short stature: A meta-analysis
Deep Dutta, Ritesh Agrawal, Ameya Joshi, et al.
Journal of Pediatric Endocrinology and Diabetes (2024) Vol. 4, pp. 21-30
Closed Access | Times Cited: 2
Deep Dutta, Ritesh Agrawal, Ameya Joshi, et al.
Journal of Pediatric Endocrinology and Diabetes (2024) Vol. 4, pp. 21-30
Closed Access | Times Cited: 2
Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
Min Kyong Moon, Kyu Yeon Hur, Seung-Hyun Ko, et al.
The Korean Journal of Internal Medicine (2017) Vol. 32, Iss. 6, pp. 974-983
Open Access | Times Cited: 21
Min Kyong Moon, Kyu Yeon Hur, Seung-Hyun Ko, et al.
The Korean Journal of Internal Medicine (2017) Vol. 32, Iss. 6, pp. 974-983
Open Access | Times Cited: 21
Antidiabetic effect of gemigliptin: a systematic review and meta-analysis of randomized controlled trials with Bayesian inference through a quality management system
Hojin Oh, Hai Duc Nguyen, In Mo Yoon, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Hojin Oh, Hai Duc Nguyen, In Mo Yoon, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Gemigliptin: Newer promising gliptin for type 2 diabetes mellitus
Manish Gutch, Abhay Joshi, Sukriti Kumar, et al.
Indian Journal of Endocrinology and Metabolism (2017) Vol. 21, Iss. 6, pp. 898-898
Open Access | Times Cited: 14
Manish Gutch, Abhay Joshi, Sukriti Kumar, et al.
Indian Journal of Endocrinology and Metabolism (2017) Vol. 21, Iss. 6, pp. 898-898
Open Access | Times Cited: 14
Individual dipeptidyl peptidase‐4 inhibitors and acute kidney injury in patients with type 2 diabetes: A systematic review and network meta‐analysis
Satoru Mitsuboshi, Makoto Morizumi, Kazumasa Kotake, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 71-80
Closed Access | Times Cited: 1
Satoru Mitsuboshi, Makoto Morizumi, Kazumasa Kotake, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 71-80
Closed Access | Times Cited: 1
Efficacy and safety of fixed‐dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double‐blind, controlled, phase 3 trial
Ji Cheol Bae, Kyung Wan Min, Yong Hyun Kim, et al.
Diabetes Obesity and Metabolism (2018) Vol. 21, Iss. 1, pp. 103-111
Closed Access | Times Cited: 9
Ji Cheol Bae, Kyung Wan Min, Yong Hyun Kim, et al.
Diabetes Obesity and Metabolism (2018) Vol. 21, Iss. 1, pp. 103-111
Closed Access | Times Cited: 9
Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus
Chu Lin, Xiaoling Cai, Wenjia Yang, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Chu Lin, Xiaoling Cai, Wenjia Yang, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study
Kyung Ah Han, You‐Cheol Hwang, Shinje Moon, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3743-3752
Closed Access
Kyung Ah Han, You‐Cheol Hwang, Shinje Moon, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3743-3752
Closed Access
Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)
Byung‐Wan Lee, Kyung Wan Min, Eun‐Gyoung Hong, et al.
Endocrinology and Metabolism (2023) Vol. 38, Iss. 3, pp. 328-337
Open Access | Times Cited: 1
Byung‐Wan Lee, Kyung Wan Min, Eun‐Gyoung Hong, et al.
Endocrinology and Metabolism (2023) Vol. 38, Iss. 3, pp. 328-337
Open Access | Times Cited: 1
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
Min Kyong Moon
Journal of Korean Diabetes (2018) Vol. 19, Iss. 1, pp. 23-23
Open Access | Times Cited: 1
Min Kyong Moon
Journal of Korean Diabetes (2018) Vol. 19, Iss. 1, pp. 23-23
Open Access | Times Cited: 1
Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi‐heart study
Seung Min Chung, Jun Sung Moon, Jun Hwa Hong, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2181-2190
Closed Access
Seung Min Chung, Jun Sung Moon, Jun Hwa Hong, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2181-2190
Closed Access
A prospective cohort study on effects of gemigliptin on cardiovascular outcomes in patients with type 2 diabetes (OPTIMUS study)
Eun Heui Kim, Sang Soo Kim, Dong Jun Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access
Eun Heui Kim, Sang Soo Kim, Dong Jun Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access
Sojourn of Gemigliptin: A Hidden Gem?
Awadhesh Kumar Singh
Clinical Diabetology (2022) Vol. 11, Iss. 3, pp. 131-134
Open Access
Awadhesh Kumar Singh
Clinical Diabetology (2022) Vol. 11, Iss. 3, pp. 131-134
Open Access
